Home › Occupations › Bioengineers and Biomedical Engineers › Milpitas, CA
Bioengineers and Biomedical Engineers in Milpitas, CA: H-1B salaries
22 labor condition applications for this occupation with a work site in Milpitas, CA. Median offered base salary $125,694; middle half $105,269–$146,576.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $105,269 |
| Level II (qualified) | $105,600 |
| Level III (experienced) | $146,250 |
| Level IV (fully competent) | $150,000 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| Becton, Dickinson and Company | 7 | $145,000 |
| Stellartech Research Corporation | 3 | $95,000 |
| N1 Life Inc | 2 | $118,800 |
| Topcon Healthcare Inc. | 2 | $131,750 |
| Augusta Life Sciences US OpCo I LLC | 2 | $127,634 |
| Bigfoot Biomedical, Inc. | 1 | $146,576 |
| Elixir Medical Corporation | 1 | $75,275 |
| VitroLabs Inc. | 1 | $96,000 |
| OBiO Tech, Inc. | 1 | — |
| Galaxy Therapeutics Inc | 1 | $105,000 |
| Tiposi | 1 | $125,694 |
Job titles
- Quality Engineer2
- Staff Quality Engineer2
- Senior Systems Design Assurance Engineer1
- Quality Assurance Engineer I1
- R&D Engineer1
- Research Scientist1
- Research Associate1
- Process Development Engineer II1
- Engineering Project Manager, Program Management1
- Staff Engineer I, Systems Verification1
- Senior Application Scientist1
- Research and Development Engineer1
- Research Scientist, Image Processing R&D1
- Senior I, Systems Verification Scientist1
- Senior Global Service Engineer1
H-1B sponsors in Milpitas, CA →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).